赛升药业: 董事会决议公告

Meeting Details - The fifth board meeting of Beijing Saiseng Pharmaceutical Co., Ltd. was held on August 20, 2025, with all 8 participating directors present [1] - The meeting was legally convened in accordance with relevant laws and regulations [1] Resolutions Passed - The board approved the 2025 semi-annual report and its summary, confirming that the report complies with legal and regulatory requirements and accurately reflects the company's situation without any false statements or omissions [1][2] - The board agreed to use up to RMB 1.2 billion of idle funds for investment and financial management, with a validity period of one year from the date of shareholder meeting approval, and individual investment products not exceeding 12 months [2]